Details of Disease

General Information of Disease (ID: DIS4AO5Z)

• Disease Name: Acute bacterial skin infection
• Disease Class: 1A00-1C4Z: Bacterial infection
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DIS4AO5Z: Acute bacterial skin infection
• ICD Code: ICD-11: ICD-11: 1C41

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Delafloxacin Meglumine	DMVTU5Q	Approved	Small molecular drug	[1]
Lefamulin	DME6G97	Approved	NA	[2]
Omadacycline	DMR2J95	Approved	NA	[3]

This Disease is Treated as An Indication in 7 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
GSK2140944	DMSMFN2	Phase 3	NA	[2]
Iclaprim	DM7YNV9	Phase 3	Small molecular drug	[2]
Sivextro	DMFY0MX	Phase 3	NA	[2]
Afabicin	DMFO2G5	Phase 2	NA	[2]
Brilacidin	DMXI9BP	Phase 2	Small molecular drug	[2]
Contepo	DMLKT6O	Phase 2	NA	[2]
Contezolid acefosamil	DMMOHUA	Phase 2	NA	[2]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Omadacycline Enters the Ring: A New Antimicrobial Contender.Pharmacotherapy. 2018 Dec;38(12):1194-1204.